MIR3648-2

Across TCGA pan-cancer cohorts, MIR3648-2 RNA is linked to patient survival in 5 of 34 cancer types, making it the most broadly survival-associated MIR3648-2 data layer.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where higher MIR3648-2 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MIR3648-2 expression acts as an unfavorable survival marker, although some lineages such as LAML show a favorable association.

LUSC, SKCM, and THYM are the cancer types where MIR3648-2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUSC	DFS	Tertile	All	0.196	0.664	<.001	96	view →
SKCM	DFS	Tertile	All	0.225	0.740	<.001	63	view →
THYM	DFS	Tertile	All	0.123	0.871	<.001	36	view →
SARC	OS	Tertile	All	0.029	0.839	<.001	36	view →
LAML	DFS	Median	All	0.672	0.485	.012	14	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

MIR3648-2–LUSC (DFS)

Open the LUSC breakdown →